Patents by Inventor Hae-Kyung SUH

Hae-Kyung SUH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11623910
    Abstract: The present invention relates to a compound isolated from Torilidis Fructus, and an anticancer pharmaceutical composition containing same as an active ingredient, wherein the compound of the present invention has effects of reducing the viability of various types of cancer cells, having no effect on the cell viability of normal cells and reducing the tumor size and weight of lung cancer and colorectal cancer when used in an animal model. Therefore, the compound according to the present invention can be usefully used in anticancer drugs or health functional food industries.
    Type: Grant
    Filed: February 15, 2021
    Date of Patent: April 11, 2023
    Assignees: PHARMA-GENE CO., LTD., J-MEDIZIN CO., LTD
    Inventors: Young-Min Kim, Hae-Kyung Suh
  • Publication number: 20230107983
    Abstract: The present invention relates to a compound isolated from Torilidis Fructus, and an anticancer pharmaceutical composition containing same as an active ingredient, wherein the compound of the present invention has effects of reducing the viability of various types of cancer cells, having no effect on the cell viability of normal cells and reducing the tumor size and weight of lung cancer and colorectal cancer when used in an animal model. Therefore, the compound according to the present invention can be usefully used in anticancer drugs or health functional food industries.
    Type: Application
    Filed: February 15, 2021
    Publication date: April 6, 2023
    Applicants: PHARMA-GENE CO., LTD., J-MEDIZIN CO.,LTD
    Inventors: Young-Min KIM, Hae-Kyung SUH